David L Porter Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2023	Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.
10/2020	Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children.
10/2020	Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia.
1/2020	Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
1/2020	CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.
1/2020	Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation.
11/2019	Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).
1/2019	Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
11/2017	Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia.
2/2017	Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Porter Research Topics

Disease

52	Neoplasms (Cancer) 04/2024 - 01/2002
19	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 04/2013
18	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2002
17	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 12/2011
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 08/2011
14	Cytokine Release Syndrome 12/2023 - 04/2013
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2003
14	Leukemia 12/2017 - 01/2002
13	Lymphoma (Lymphomas) 01/2023 - 09/2005
10	Infections 01/2023 - 01/2004
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 05/2006
8	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 01/2016
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 06/2003
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 12/2017
4	Bronchiolitis Obliterans Syndrome 01/2018 - 10/2012
3	Cytopenia 03/2024 - 08/2013
3	Pain (Aches) 02/2024 - 01/2021
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 12/2017
3	Critical Illness (Critically Ill) 10/2020 - 01/2016
3	Body Weight (Weight, Body) 10/2014 - 08/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2009 - 02/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 02/2015
2	Febrile Neutropenia 01/2023 - 12/2022
2	cell-associated neurotoxicity 10/2022 - 11/2020
2	Multiple Myeloma 06/2022 - 01/2016
2	Mucositis 06/2022 - 01/2021
2	Liver Diseases (Liver Disease) 01/2019 - 01/2018
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 02/2008
2	Liver Failure 01/2018 - 01/2018
2	Lymphopenia (Lymphocytopenia) 08/2011 - 11/2005
2	Tumor Lysis Syndrome 08/2011 - 05/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2009 - 05/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2005 - 11/2002
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024
1	Frailty 01/2024
1	Experimental Melanoma 01/2023
1	Dysbiosis 01/2023
1	Hemorrhagic Cystitis 10/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2022
1	Viremia 10/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Vitamin D Deficiency 01/2022
1	Capillary Leak Syndrome 11/2020

Drug/Important Bio-Agent (IBA)

51	Chimeric Antigen ReceptorsIBA 03/2024 - 08/2011
12	tisagenlecleucelIBA 01/2023 - 04/2013
8	AntigensIBA 01/2023 - 01/2006
5	CytokinesIBA 11/2020 - 09/2003
4	fludarabineIBA 12/2023 - 07/2013
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 08/2015
4	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 07/2013
4	tocilizumab (atlizumab)FDA Link 01/2020 - 04/2013
4	Maraviroc FDA Link 03/2019 - 07/2015
3	Bendamustine Hydrochloride FDA Link 04/2024 - 12/2023
3	axicabtagene ciloleucelIBA 12/2023 - 10/2022
3	venetoclaxIBA 01/2023 - 01/2022
3	Busulfan (Busulfex)FDA Link 01/2023 - 07/2013
3	ibrutinibIBA 11/2022 - 02/2016
3	Tacrolimus (Prograf)FDA LinkGeneric 03/2019 - 07/2013
2	Calcineurin InhibitorsIBA 02/2024 - 08/2015
2	Vancomycin FDA LinkGeneric 01/2023 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022 - 01/2002
2	SteroidsIBA 01/2022 - 01/2019
2	Etanercept (Enbrel)FDA Link 01/2022 - 04/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2002
2	trans-crotonin (CTN)IBA 01/2021 - 03/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2016
2	Bortezomib (Velcade)FDA Link 03/2019 - 08/2014
2	CTL019 chimeric antigen receptorIBA 12/2018 - 04/2013
2	Thomsen-Friedenreich antibodiesIBA 12/2017 - 06/2011
2	AntibodiesIBA 01/2016 - 06/2011
2	Monoclonal AntibodiesIBA 01/2014 - 06/2003
1	brexucabtagene autoleucelIBA 03/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024
1	Interferon Type IIBA 01/2023
1	Clofarabine (Clolar)FDA Link 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 12/2022
1	CPX-351IBA 12/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 10/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Basiliximab FDA Link 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2021

Therapy/Procedure

44	Therapeutics 03/2024 - 01/2002
22	Immunotherapy 01/2024 - 01/2006
20	Stem Cell Transplantation 01/2023 - 01/2002
19	Cell Transplantation 02/2024 - 09/2003
17	Transplantation 01/2023 - 09/2008
15	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
15	Hematopoietic Stem Cell Transplantation 01/2018 - 07/2006
4	Homologous Transplantation 01/2024 - 06/2010
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 04/2014
3	Induction Chemotherapy 08/2013 - 02/2006
2	Length of Stay 06/2022 - 01/2021
2	Organ Transplantation 01/2018 - 10/2005
2	Radiotherapy 01/2013 - 02/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2002 - 01/2002
1	Salvage Therapy 01/2022
1	Nutritional Support (Artificial Feeding) 01/2021